RxDoctor Payments Data

Shari Thompson, MD

Family Medicine · Marshall, MONPI 1700889367

Payments from drug & device makers

$378in general payments, 2019–2025

Across 24 payments — averaging $15.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$53
  • Merck$51
  • Amgen$48
  • AstraZeneca$31
  • Organon$31
  • Phadia US Inc.$24
  • plus $139 from 8 others

What the payments were for

  • Food & beverage$378100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$378 in reported general payments places this provider in the 50th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$2,841
Medicare patients
73
Services billed
203

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban57$41,561
OzempicSemaglutide41$39,561
RybelsusSemaglutide22$25,679
TrulicityDulaglutide23$23,799
JardianceEmpagliflozin20$18,732
Tresiba Flextouch U-100Insulin Degludec17$14,539
Fiasp FlextouchInsulin Aspart (Niacinamide)11$13,767
Combivent RespimatIpratropium/Albuterol Sulfate21$12,466
Spiriva RespimatTiotropium Bromide18$11,153
TradjentaLinagliptin14$7,195
JanuviaSitagliptin Phosphate12$6,711
Repatha SureclickEvolocumab12$6,617
Insulin Lispro Kwikpen U-100Insulin Lispro36$5,012
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog13$4,954
Novolog FlexpenInsulin Aspart28$4,527

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$53$65,24063 claims
Boehringer IngelheimJardiance, Combivent Respimat, Spiriva Respimat, Tradjenta$16$49,54673 claims
PfizerEliquis$17$41,56157 claims
Lilly USA, LLCTrulicity$13$23,79923 claims
MerckJanuvia$51$6,71112 claims
AstraZenecaSymbicort$31$4,22417 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 2,203 family medicine providers in Missouri.

Other family medicine in Marshall

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →